High prevalence of impaired glucose metabolism among children and adolescents living with HIV in Ghana.
adolescents
children
impaired glucose metabolism
paediatric HIV
Journal
HIV medicine
ISSN: 1468-1293
Titre abrégé: HIV Med
Pays: England
ID NLM: 100897392
Informations de publication
Date de publication:
19 Jan 2024
19 Jan 2024
Historique:
received:
12
10
2023
accepted:
08
01
2024
medline:
19
1
2024
pubmed:
19
1
2024
entrez:
19
1
2024
Statut:
aheadofprint
Résumé
Antiretroviral therapy (ART)-associated metabolic abnormalities, including impairment of glucose metabolism, are prevalent in adults living with HIV. However, the prevalence and pathogenesis of impaired glucose metabolism in children and adolescents living with HIV, particularly in sub-Saharan Africa, are not well characterized. We investigated the prevalence of impaired glucose metabolism among children and adolescents living with perinatally infected HIV in Ghana. In this multicentre, cross-sectional study, we recruited participants from 10 paediatric antiretroviral treatment clinics from January to June 2022 in 10 facilities in Greater Accra and Eastern regions of Ghana. We determined impaired glucose metabolism in the study sample by assessing fasting blood sugar (FBS), insulin resistance as defined by the homeostatic model assessment for insulin resistance (HOMA-IR) index and glycated haemoglobin (HbA1c) levels. The prevalence of impaired glucose metabolism using each criterion was stratified by age and sex. The phenotypic correlates of glucose metabolism markers were also assessed among age, sex, body mass index (BMI) and waist-to-hip ratio (WHR). We analysed data from 393 children and adolescents living with HIV aged 6-18 years. A little over half (205/393 or 52.25%) of the children were female. The mean age of the participants was 11.60 years (SD = 3.50), with 122/393 (31.00%) aged 6-9 years, 207/393 (52.67%) aged 10-15 years, and 62/393 (15.78%) aged 16-18 years. The prevalence rates of glucose impairment in the study population were 15.52% [95% confidence interval (CI): 12.26-19.45], 22.39% (95% CI: 18.54-26.78), and 26.21% (95% CI: 22.10-30.78) using HbA1c, HOMA-IR, and FBS criteria, respectively. Impaired glucose metabolism detected by FBS and HOMA-IR was higher in the older age group, whereas the prevalence of abnormal HbA1c levels was highest among the youngest age group. Age and BMI were positively associated with FBS and HOMA-IR (p < 0.001). However, there was negative correlation of WHR with HOMA-IR (p < 0.01) and HbA1c (p = 0.01). The high prevalence of impaired glucose metabolism observed among the children and adolescents living with HIV in sub-Saharan Africa is of concern as this could contribute to the development of metabolic syndrome in adulthood.
Sections du résumé
BACKGROUND
BACKGROUND
Antiretroviral therapy (ART)-associated metabolic abnormalities, including impairment of glucose metabolism, are prevalent in adults living with HIV. However, the prevalence and pathogenesis of impaired glucose metabolism in children and adolescents living with HIV, particularly in sub-Saharan Africa, are not well characterized. We investigated the prevalence of impaired glucose metabolism among children and adolescents living with perinatally infected HIV in Ghana.
METHODS
METHODS
In this multicentre, cross-sectional study, we recruited participants from 10 paediatric antiretroviral treatment clinics from January to June 2022 in 10 facilities in Greater Accra and Eastern regions of Ghana. We determined impaired glucose metabolism in the study sample by assessing fasting blood sugar (FBS), insulin resistance as defined by the homeostatic model assessment for insulin resistance (HOMA-IR) index and glycated haemoglobin (HbA1c) levels. The prevalence of impaired glucose metabolism using each criterion was stratified by age and sex. The phenotypic correlates of glucose metabolism markers were also assessed among age, sex, body mass index (BMI) and waist-to-hip ratio (WHR).
RESULTS
RESULTS
We analysed data from 393 children and adolescents living with HIV aged 6-18 years. A little over half (205/393 or 52.25%) of the children were female. The mean age of the participants was 11.60 years (SD = 3.50), with 122/393 (31.00%) aged 6-9 years, 207/393 (52.67%) aged 10-15 years, and 62/393 (15.78%) aged 16-18 years. The prevalence rates of glucose impairment in the study population were 15.52% [95% confidence interval (CI): 12.26-19.45], 22.39% (95% CI: 18.54-26.78), and 26.21% (95% CI: 22.10-30.78) using HbA1c, HOMA-IR, and FBS criteria, respectively. Impaired glucose metabolism detected by FBS and HOMA-IR was higher in the older age group, whereas the prevalence of abnormal HbA1c levels was highest among the youngest age group. Age and BMI were positively associated with FBS and HOMA-IR (p < 0.001). However, there was negative correlation of WHR with HOMA-IR (p < 0.01) and HbA1c (p = 0.01).
CONCLUSION
CONCLUSIONS
The high prevalence of impaired glucose metabolism observed among the children and adolescents living with HIV in sub-Saharan Africa is of concern as this could contribute to the development of metabolic syndrome in adulthood.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : FIC NIH HHS
ID : D43 TW011526
Pays : United States
Informations de copyright
© 2024 British HIV Association.
Références
Feinstein L, Edmonds A, Chalachala JL, et al. Temporal changes in the outcomes of HIV-exposed infants in Kinshasa, Democratic Republic of Congo during a period of rapidly evolving guidelines for care (2007-2013). Aids. 2014;28(Suppl 3):S301-S311.
Anuurad E, Semrad A, Berglund L. Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease. Metab Syndr Relat Disord. 2009;7(5):401-409.
Jericó C, Knobel H, Montero M, et al. Metabolic syndrome among HIV-infected patients. Diabetes Care. 2005;28(1):132-137.
Maganga E, Smart LR, Kalluvya S, et al. Glucose metabolism disorders, HIV and antiretroviral therapy among Tanzanian adults. PLOS One. 2015;10(8):e0134410.
Satlin MJ, Hoover DR, Glesby MJ. Glycemic control in HIV-infected patients with diabetes mellitus and rates of meeting American Diabetes Association management guidelines. AIDS Patient Care STDS. 2011;25(1):5-12.
Ryom L, Lundgren JD, El-Sadr W, et al. Cardiovascular disease and use of contemporary protease inhibitors: the D:a:D international prospective multicohort study. Lancet HIV. 2018;5(6):e291-e300.
Nkinda L, Buberwa E, Memiah P, et al. Impaired fasting glucose levels among perinatally HIV-infected adolescents and youths in Dar es Salaam, Tanzania. Front Endocrinol. 2022;13:1045628.
Reng SR, Uloko EA, Puepet HF, Onwuegbuzie AG, Ramalan AM. Prevalence and determinants of glucose intolerance among HIV/AIDS patients in north-central Nigeria. Niger J Med J Natl Assoc Resid Dr Niger. 2016;25(2):128-132.
Innes S, Abdullah KL, Haubrich R, Cotton MF, Browne SH. High prevalence of dyslipidemia and insulin resistance in HIV-infected Prepubertal African children on antiretroviral therapy. Pediatr Infect Dis J. 2016;35(1):e1-e7.
Gast KB, Tjeerdema N, Stijnen T, Smit JWA, Dekkers OM. Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLoS ONE. 2012;7(12):e52036.
Yajnik CS, Katre PA, Joshi SM, et al. Higher glucose, insulin and insulin resistance (HOMA-IR) in childhood predict adverse cardiovascular risk in early adulthood: the Pune Children's study. Diabetologia. 2015;58(7):1626-1636.
Assunção SNFD, Boa Sorte NCA, Alves CDAD, Mendes PSA, Alves CRB, Silva LR. Glucose alteration and insulin resistance in asymptomatic obese children and adolescents. J Pediatr (Rio J). 2018;94(3):268-272.
Al-Daghri NM, Al-Attas OS, Alokail M, et al. Does visceral adiposity index signify early metabolic risk in children and adolescents?: association with insulin resistance, adipokines, and subclinical inflammation. Pediatr Res. 2014;75(3):459-463.
Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep. 2004;4(1):53-62.
Reisi M, Keivanfar M, Mostofizadeh N, Madihi Y, Esmaeilian Y, Hashemi E. Correlation between stable hyperglycemia and mortality in children admitted to the pediatric intensive care unit of imam Hossein hospital. Adv Biomed Res. 2021;10(1):2.
Rivera DM, Frye RE. Pediatric HIV Infection. Medscape Drug Reference [Internet]. 2020 Available from: https://emedicine.medscape.com/article/965086-overview#a1
Paganella MP, Cohen RA, Harris DR, et al. Association of Dyslipidemia and Glucose Abnormalities with Antiretroviral Treatment in a cohort of HIV-infected Latin American children. JAIDS J Acquir Immune Defic Syndr. 2017;74(1):e1-e8.
Salako AO, Gbaja-Biamila TA, Ezemelue PN, et al. Metabolic syndrome among adolescents and young adults living with HIV in Lagos: a cross-sectional study. Glob Pediatr. 2021;1:100001.
Das RR, Mangaraj M, Panigrahi SK, Satapathy AK, Mahapatro S, Ray PS. Metabolic syndrome and insulin resistance in schoolchildren from a developing country. Front Nutr. 2020;7:31.
Chantry CJ, Hughes MD, Alvero C, et al. Insulin-like growth Factor-1 and lean body mass in HIV-infected children. JAIDS J Acquir Immune Defic Syndr. 2008;48(4):437-443.
Rosso R, Parodi A, d'Annunzio G, et al. Evaluation of insulin resistance in a cohort of HIV-infected youth. Eur J Endocrinol. 2007;157(5):655-659.
Ghana demographics and health survey. Ghana demographics and health survey, Final Report. GSS and GHS. 2014 https://dhsprogram.com/methodology/survey/survey-display-437.cfm
National AIDS/STI Control Programme. Ghana Health Service. Consolidated Guidelines for HIV Care in Ghana Test, Treat & Track. 2019 https://ghs.gov.gh/wp-content/uploads/2022/10/Consolidated-HIV-Guidelines.pdf
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and?-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412-419.
World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Production. 2006 https://apps.who.int/iris/handle/10665/43588
Gillett MJ. International expert committee report on the role of the A1c assay in the diagnosis of diabetes: diabetes. Clin Biochem Rev. 2009;30(4):197-200.
Lee JM, Gebremariam A, Wu EL, LaRose J, Gurney JG. Evaluation of nonfasting tests to screen for childhood and adolescent Dysglycemia. Diabetes Care. 2011;34(12):2597-2602.
Center for Disease Control and Prevention. Diabetes Tests. https://www.cdc.gov/diabetes/basics/getting-tested.html
Rubin M. When to Adjust Alpha during Multiple Testing: A Consideration of Disjunction, Conjunction, and Individual Testing. 2023 https://arxiv.org/abs/2107.02947
Tricò D, Natali A, Arslanian S, Mari A, Ferrannini E. Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents. JCI Insight. 2018;3(24):e124912.
Ogum Alangea D, Aryeetey RN, Gray HL, Laar AK, Adanu RMK. Dietary patterns and associated risk factors among school age children in urban Ghana. BMC Nutr. 2018;4(1):22.
Wang J, Light K, Henderson M, et al. Consumption of added sugars from liquid but not solid sources predicts impaired glucose homeostasis and insulin resistance among youth at risk of obesity. J Nutr. 2014;144(1):81-86.
Santiprabhob J, Tanchaweng S, Maturapat S, et al. Metabolic disorders in HIV-infected adolescents receiving protease inhibitors. Biomed Res Int. 2017;2017:1-14.
Vijayakumar P, Nelson RG, Hanson RL, Knowler WC, Sinha M. HbA1c and the prediction of type 2 diabetes in children and adults. Diabetes Care. 2017;40(1):16-21.
Ketha F, Beatriz P, Sandra T, et al. Insulin resistance and glucose intolerance in HIV infected children on antiretroviral therapy at Lubango pediatric hospital - Angola. Int J Virol AIDS. 2020;7:3.
Noumegni SRN, Nansseu JR, Ama VJM, et al. Insulin resistance and associated factors among HIV-infected patients in sub-Saharan Africa: a cross sectional study from Cameroon. Lipids Health Dis. 2017;16(1):148.
Geffner ME, Patel K, Miller TL, et al. Factors associated with insulin resistance among children and adolescents perinatally infected with HIV-1 in the pediatric HIV/AIDS cohort study. Horm Res Paediatr. 2011;76(6):386-391.
Geffner ME, Patel K, Jacobson DL, et al. Changes in insulin sensitivity over time and associated factors in HIV-infected adolescents. Aids. 2018;32(5):613-622.
Taheri F, Bijari B, Kazemi T, Namakin K, Zardast M, Chahkandi T. Prevalence of high normal FBS and prediabetes among adolescents in Birjand, east of Iran, 2012. J Educ Health Promot. 2015;4(1):68.
Levitt NS, Peer N, Steyn K, et al. Increased risk of dysglycaemia in south Africans with HIV; especially those on protease inhibitors. Diabetes Res Clin Pract. 2016;119:41-47.
McCarthy HD, Ashwell M. A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message-‘keep your waist circumference to less than half your height’. Int J Obes (Lond). 2006;30(6):988-992.
Kułaga Z, Świąder-Leśniak A, Kotowska A, Litwin M. Population-based references for waist and hip circumferences, waist-to-hip and waist-to-height ratios for children and adolescents, and evaluation of their predictive ability. Eur J Pediatr. 2023;182(7):3217-3229.
Tzur F, Chowers M, Agmon-Levin N, Mekori YA, Hershko AY. Increased prevalence of diabetes mellitus in a non-obese adult population: HIV-infected Ethiopians. Isr Med Assoc J IMAJ. 2015;17(10):620-623.
Fox AM. The HIV-poverty thesis Re-examined: poverty, wealth or inequality as a social determinant of HIV infection in sub-Saharan Africa? J Biosoc Sci. 2012;44(4):459-480.
Nathan DM, Kuenen J, Borg R, et al. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-1478.
Wegmüller R, Bentil H, Wirth JP, et al. Anemia, micronutrient deficiencies, malaria, hemoglobinopathies and malnutrition in young children and non-pregnant women in Ghana: findings from a national survey. PLOS One. 2020;15(1):e0228258.
Guerrero-Romero F, Violante R, Rodríguez-Morán M. Distribution of fasting plasma glucose and prevalence of impaired fasting glucose, impaired glucose tolerance and type 2 diabetes in the Mexican paediatric population. Paediatr Perinat Epidemiol. 2009;23(4):363-369.
Sinha R, Fisch G, Teague B, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med. 2002;346(11):802-810.
Dimock D, Thomas V, Cushing A, et al. Longitudinal assessment of metabolic abnormalities in adolescents and young adults with HIV-infection acquired perinatally or in early childhood. Metabolism. 2011;60(6):874-880.
Frigati LJ, Jao J, Mahtab S, et al. Insulin resistance in south African youth living with perinatally acquired HIV receiving antiretroviral therapy. AIDS Res Hum Retroviruses. 2019;35(1):56-62.